Estimation of biliary excretion of foreign compounds using properties of molecular structure.

Predicting when biliary excretion of parent drug is a major route of elimination in humans. AAPS J (2014) 0.83

Predicting the extent of metabolism using in vitro permeability rate measurements and in silico permeability rate predictions. Mol Pharm (2015) 0.78

Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci U S A (2003) 5.77

Biliary excretion of foreign compounds. Biphenyl, stilboestrol and phenolphthalein in the rat: molecular weight, polarity and metabolism as factors in biliary excretion. Biochem J (1967) 5.33

Biliary excretion of foreign compounds. Benzene and its derivatives in the rat. Biochem J (1967) 3.97

The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch (2003) 3.81

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci U S A (1997) 3.20

Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev (2003) 3.07

Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver. Hepatology (2009) 2.59

Species variations in the threshold molecular-weight factor for the biliary excretion of organic anions. Biochem J (1972) 1.57

Monocarboxylate transporter 1 (MCT1) in the liver of pre-ruminant and adult bovines. Vet J (2005) 1.40

Development of linear, ensemble, and nonlinear models for the prediction and interpretation of the biological activity of a set of PDGFR inhibitors. J Chem Inf Comput Sci (2004) 1.38

Nelfinavir: an update on its use in HIV infection. Drugs (2000) 1.35

Hepatic transport of bile salts. Semin Liver Dis (2000) 1.31

Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug Metab Dispos (2008) 1.29

Lipophilicity in PK design: methyl, ethyl, futile. J Comput Aided Mol Des (2001) 1.22

Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol Sci (2010) 1.22

The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin. Mol Pharmacol (2005) 1.20

Drug uptake systems in liver and kidney. Curr Drug Metab (2003) 1.14

Differential involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in biliary excretion of 4-methylumbelliferyl glucuronide and sulfate in the rat. J Pharmacol Exp Ther (2006) 1.13

QSAR and ADME. Bioorg Med Chem (2004) 1.12

Biliary excretion of drugs in man. Clin Pharmacokinet (1980) 1.11

Prediction of biliary excretion in rats and humans using molecular weight and quantitative structure-pharmacokinetic relationships. AAPS J (2009) 1.01

Pharmacokinetics of fosmidomycin, a new phosphonic acid antibiotic. Antimicrob Agents Chemother (1982) 0.96

Clinical pharmacokinetics of therapeutic bile acids. Clin Pharmacokinet (1996) 0.91

Relationship between chemical structure and physicochemical properties of series of bulky organic cations and their hepatic uptake and biliary excretion rates. J Pharmacol Exp Ther (1997) 0.87

QSPR models for the prediction of apparent volume of distribution. Int J Pharm (2006) 0.85

Physicochemical property space of hepatobiliary transport and computational models for predicting rat biliary excretion. Drug Metab Dispos (2012) 0.85

Structure-pharmacokinetic relationship of in vivo rat biliary excretion. Biopharm Drug Dispos (2010) 0.84

In silico prediction of biliary excretion of drugs in rats based on physicochemical properties. Drug Metab Dispos (2009) 0.84

Human CYPs involved in drug metabolism: structures, substrates and binding affinities. Expert Opin Drug Metab Toxicol (2010) 0.83

In silico insights: chemical and structural characteristics associated with uridine diphosphate-glucuronosyltransferase substrate selectivity. Clin Exp Pharmacol Physiol (2003) 0.83

Coping with unbalanced class data sets in oral absorption models. J Chem Inf Model (2013) 0.81

A comparison between two polarizability parameters in chemical--biological interactions. Bioorg Med Chem (2005) 0.80

Hepatic uptake and biliary excretion of organic cations--I. Characterization of three new model compounds. Biochem Pharmacol (1984) 0.77

Reevaluation of a quantitative structure pharmacokinetic model for biliary excretion in rats. Drug Metab Dispos (2012) 0.76

Unequal disposition of enantiomers of the organic cation oxyphenonium in the rat isolated perfused liver. J Pharm Pharmacol (1989) 0.76

Draize rabbit eye test compatibility with eye irritation thresholds in humans: a quantitative structure-activity relationship analysis. Toxicol Sci (2003) 0.90

Karanjin interferes with ABCB1, ABCC1, and ABCG2. J Pharm Pharm Sci (2014) 0.87

Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists. J Mol Graph Model (2007) 0.81

Coping with unbalanced class data sets in oral absorption models. J Chem Inf Model (2013) 0.81

Differential effects of the oncogenic BRAF inhibitor PLX4032 (vemurafenib) and its progenitor PLX4720 on ABCB1 function. J Pharm Pharm Sci (2014) 0.81

Comparing multilabel classification methods for provisional biopharmaceutics class prediction. Mol Pharm (2014) 0.77

Pre-processing feature selection for improved C&RT models for oral absorption. J Chem Inf Model (2013) 0.76

Solubility prediction of paracetamol in water-ethanol-propylene glycol mixtures at 25 and 30 degrees C using practical approaches. Chem Pharm Bull (Tokyo) (2008) 0.75

The effect of formulations and experimental conditions on in vitro human skin permeation-Data from updated EDETOX database. Int J Pharm (2012) 0.75